{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:54:52Z","timestamp":1781830492400,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.02.014","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:23:39Z","timestamp":1771028619000},"page":"2879-2889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-capacity adenoviral vector-mediated expression of an LDLR\/transferrin chimeric protein in muscle reduces atherosclerosis in Ldlr\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-3132","authenticated-orcid":false,"given":"Maria","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Scial\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Coluccino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorella","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cerullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6894-9317","authenticated-orcid":false,"given":"Lucio","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.02.014_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/biomedicines10051043","article-title":"Recent Advances on Familial Hypercholesterolemia in Children and Adolescents","volume":"10","author":"Mainieri","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2026.02.014_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ymthe.2026.02.014_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action","volume":"5","author":"Representatives of the Global Familial Hypercholesterolemia Community","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ymthe.2026.02.014_bib4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2026.02.014_bib5","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2014.01.060","article-title":"The severe hypercholesterolemia phenotype: Clinical diagnosis, management, and emerging therapies","volume":"63","author":"Sniderman","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2026.02.014_bib6","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00018-005-5231-z","article-title":"Molecular mechanisms of lipoprotein receptor signalling","volume":"62","author":"May","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2026.02.014_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/biom12020158","article-title":"Approaches to Visualising Endocytosis of LDL-Related Lipoproteins","volume":"12","author":"Siddiqui","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2026.02.014_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/104303404323141980","article-title":"Fusion Protein : In Vivo Production and Functional Evaluation as a Potential Therapeutic Tool for Lowering Plasma LDL Cholesterol","volume":"15","author":"Razzini","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.addr.2012.02.007","article-title":"Synthetic cell surface receptors for delivery of therapeutics and probes","volume":"64","author":"Hymel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2026.02.014_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2026.02.014_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026550","article-title":"Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries","volume":"12","author":"Arca","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ymthe.2026.02.014_bib12","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.3390\/jcm11154611","article-title":"Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk","volume":"11","author":"Rikhi","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2026.02.014_bib13","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: New treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2026.02.014_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1028355","article-title":"Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome","volume":"9","author":"Biolo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ymthe.2026.02.014_bib15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: Recent developments","volume":"185","author":"Bj\u00f6rkegren","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.02.014_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.2000.0104","article-title":"Prolonged transgene expression mediated by a helper-dependent adenoviral vector (hdAd) in the central nervous system","volume":"2","author":"Zou","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gene.2003.11.024","article-title":"Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice","volume":"327","author":"Pastore","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.ymthe.2026.02.014_bib18","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.CIR.0000066913.69844.B2","article-title":"Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia","volume":"107","author":"Belalcazar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.02.014_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.CIR.103.9.1274","article-title":"Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor","volume":"103","author":"Oka","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.02.014_bib20","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/d41586-022-04210-5","article-title":"How gene therapy is emerging from its \u2018dark age\u2019","volume":"612","author":"Conroy","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.02.014_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/hum.2023.152","article-title":"Advances and Challenges in the Development of Gene Therapy Medicinal Products for Rare Diseases","volume":"34","author":"Bueren","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041297","article-title":"Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies","volume":"15","author":"Tripodi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2026.02.014_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12951-023-02044-5","article-title":"Emerging non-viral vectors for gene delivery","volume":"21","author":"Wang","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ymthe.2026.02.014_bib24","doi-asserted-by":"crossref","first-page":"59D","DOI":"10.1016\/0002-9149(93)90012-2","article-title":"Therapeutic strategies for familial hypercholesterolemia based on somatic gene transfer","volume":"72","author":"Wilson","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymthe.2026.02.014_bib25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/lt.24122","article-title":"Liver-targeted gene therapy: Approaches and challenges","volume":"21","author":"Aravalli","year":"2015","journal-title":"Liver Transpl."},{"key":"10.1016\/j.ymthe.2026.02.014_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1755-7682-3-36","article-title":"LDLR-Gene therapy for familial hypercholesterolaemia: Problems, progress, and perspectives","volume":"3","author":"Al-Allaf","year":"2010","journal-title":"Int. Arch. Med."},{"key":"10.1016\/j.ymthe.2026.02.014_bib27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/gt.2013.38","article-title":"PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice This article has been corrected since online publication and a corrigendum is also printed in this issue","volume":"20","author":"Leggiero","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41434-019-0061-z","article-title":"Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor\/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice","volume":"26","author":"Leggiero","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib29","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/acs.jproteome.5b00213","article-title":"A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins","volume":"14","author":"Gordon","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymthe.2026.02.014_bib30","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1073\/pnas.87.21.8437","article-title":"Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes","volume":"87","author":"Wilson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.014_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/gt.2014.85","article-title":"Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector","volume":"22","author":"Oka","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.gt.3302441","article-title":"PEGylated helper-dependent adenoviral vectors: Highly efficient vectors wih an enhanced safety profile","volume":"12","author":"Croyle","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib33","article-title":"Helper-Dependent Adenoviral Vectors","volume":"5","author":"Rosewell","year":"2011","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib34","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.1073\/pnas.241506298","article-title":"Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector","volume":"98","author":"Kim","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.014_bib35","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1073\/pnas.0500930102","article-title":"Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector","volume":"102","author":"Toietta","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.014_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/humc.2017.014","article-title":"Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR+\/- Rhesus Macaques","volume":"28","author":"Greig","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.02.014_bib37","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/humc.2017.007","article-title":"Nonclinical Pharmacology\/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia","volume":"28","author":"Greig","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.02.014_bib38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/hum.2017.150","article-title":"Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial","volume":"28","author":"Vandamme","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL\/6J Mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF03402113","article-title":"Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector","volume":"6","author":"O'Neal","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymthe.2026.02.014_bib41","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.gt.3302792","article-title":"Modulation of TNF a , a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors","volume":"13","author":"Mane","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib42","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/v6020832","article-title":"The evolution of adenoviral vectors through genetic and chemical surface modifications","volume":"6","author":"Capasso","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.02.014_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute Toxicity After High-Dose Systemic Injection of Helper-Dependent Adenoviral Vectors into Nonhuman Primates","volume":"15","author":"Brunetti-Pierri","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib44","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1128\/JVI.78.11.5966-5972.2004","article-title":"Helper-Dependent Adenovirus Vectors Elicit Intact Innate but Attenuated Adaptive Host Immune Responses In Vivo","volume":"78","author":"Muruve","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.02.014_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/mp100216h","article-title":"Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus","volume":"8","author":"Wonganan","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2026.02.014_bib46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/hum.2007.0051","article-title":"Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia","volume":"18","author":"Hofherr","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/mt.2008.297","article-title":"Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy","volume":"17","author":"Seregin","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fimmu.2014.00082","article-title":"Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside","volume":"5","author":"Ferreira","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.02.014_bib49","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/10430349950017455","article-title":"Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors","volume":"10","author":"Pastore","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib50","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.96.7.3906","article-title":"Sustained correction of bleeding disorder in hemophilia B mice by gene therapy","volume":"96","author":"Wang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.014_bib51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/s12967-021-03166-w","article-title":"Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia","volume":"19","author":"Liu","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.02.014_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.02.014_bib53","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.101122498","article-title":"An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus","volume":"98","author":"Maione","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.02.014_bib54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/bit.22113","article-title":"An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection","volume":"102","author":"Dormond","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ymthe.2026.02.014_bib55","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1006\/mthe.2001.0288","article-title":"A Cre-Expressing Cell Line and an E1\/E2a Double-Deleted Virus for Preparation of Helper-Dependent Adenovirus Vector","volume":"3","author":"Zhou","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.02.014_bib56","first-page":"242","article-title":"Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes","volume":"45","author":"Tripodi","year":"2021","journal-title":"Biochim. Clinica"},{"key":"10.1016\/j.ymthe.2026.02.014_bib57","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2002.1406","article-title":"Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption","volume":"295","author":"Sweeney","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.02.014_bib58","article-title":"Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model","volume":"183","author":"Chen","year":"2022","journal-title":"J. Vis. Exp."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:34:30Z","timestamp":1781829270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626001000"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.014","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-capacity adenoviral vector-mediated expression of an LDLR\/transferrin chimeric protein in muscle reduces atherosclerosis in Ldlr\u2212\/\u2212 mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}